2006-2020年亚裔美国人卵巢癌生存的族裔差异
该研究基于SEER项目2006至2020年诊断的卵巢癌病例,按分期和组织类型计算非西班牙裔白人与七个亚裔族群的年龄标化五年病因特异性生存率,并用加权多变量Cox回归计算平均风险比(AHR)及95%CI。结果显示夏威夷/太平洋岛民是唯一生存率低于非西班牙裔白人的亚裔亚组(44.99% vs 47.90%),而亚裔印度/巴基斯坦裔生存率最高(56.12%)。调整社会人口学、肿瘤和治疗特征后,亚裔印度/巴基斯坦裔卵巢癌患者死亡风险比非西班牙裔白人低17%(AHR=0.83,95%CI 0.75-0.92),夏威夷/太平洋岛民死亡风险高28%(AHR=1.28,95%CI 1.07-1.53)。结论指出将亚裔美国人作为单一群体分析会掩盖族裔特异性生存差异,未来卵巢癌研究需要数据拆分。
要点
- 夏威夷/太平洋岛民卵巢癌五年病因特异性生存率低于非西班牙裔白人(44.99% vs 47.90%)。
- 亚裔印度/巴基斯坦裔卵巢癌患者五年病因特异性生存率最高,为56.12%。
- 调整混杂因素后,亚裔印度/巴基斯坦裔死亡风险比非西班牙裔白人低17%(AHR=0.83,95%CI 0.75-0.92)。
核心结论
- 亚裔美国人卵巢癌患者中存在明显的族裔特异性生存差异,将亚裔作为单一群体分析会掩盖这些差异,未来卵巢癌研究需要数据拆分。
研究设计与样本
- 分析SEER项目2006年至2020年诊断的卵巢癌病例,按分期和组织类型计算非西班牙裔白人与七个亚裔族群(亚裔印度/巴基斯坦裔、华裔、菲律宾裔、夏威夷/太平洋岛民、日裔、韩裔、越南裔)的年龄标化五年病因特异性生存率。
- 采用加权方法的多变量Cox回归计算平均风险比(AHR)及95%置信区间(CI),比较各亚裔族群与非西班牙裔白人卵巢癌死亡风险。
主要发现
- 夏威夷/太平洋岛民是唯一五年病因特异性生存率低于非西班牙裔白人的亚裔亚组(44.99% vs 47.90%)。
- 亚裔印度/巴基斯坦裔五年病因特异性生存率最高,为56.12%。
- 调整社会人口学、肿瘤和治疗特征后,亚裔印度/巴基斯坦裔卵巢癌患者死亡风险比非西班牙裔白人低17%(AHR=0.83,95%CI 0.75-0.92)。
- 调整后,夏威夷/太平洋岛民卵巢癌患者死亡风险比非西班牙裔白人高28%(AHR=1.28,95%CI 1.07-1.53)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Asian Americans have the highest ovarian cancer survival across the major racial groups although it is unclear whether this survival advantage is observed when each Asian ethnic subgroup is examined separately. Disaggregated survival analyses of this heterogeneous population is needed to ensure ethnic-specific disparities are not overlooked. METHODS: Data on ovarian cancer cases diagnosed from 2006 through 2020 from the Surveillance, Epidemiology, and End Results (SEER) Program were analyzed. Age-standardized five-year cause-specific survival was calculated for Non-Hispanic Whites and seven Asian ethnic subgroups in the U.S. (Asian Indian/Pakistani, Chinese, Filipino, Hawaiian/Pacific Islander, Japanese, Korean, Vietnamese) by stage and histotype. Multivariable Cox regression analyses using a weighted approach were conducted to calculate average hazard ratios (AHRs) and 95 % confidence intervals (CIs) to quantify the risk of ovarian cancer death comparing each Asian ethnic subgroup to Non-Hispanic Whites. RESULTS: Hawaiian/Pacific Islanders were the only Asian subgroup to show lower five-year cause-specific survival than Non-Hispanic Whites (44.99 % versus 47.90 %, respectively); Asian Indian/Pakistanis showed the highest survival (56.12 %). After adjusting for sociodemographic, tumor, and treatment characteristics, Asian Indian/Pakistani ovarian cancer patients were 17 % less likely to die from their disease whereas Hawaiian/Pacific Islander patients were 28 % more likely to die when compared to Non-Hispanic Whites (AHR = 0.83, 95 % CI 0.75-0.92 and AHR = 1.28, 95 % CI 1.07-1.53, respectively). CONCLUSIONS: There are clear ethnic-specific survival disparities among Asian American ovarian cancer patients that are missed when the population is examined as a single group, further highlighting the need for data disaggregation in future ovarian cancer research.
引用
- Lee AW, Poynor V, Siddiqui S, et al. Disparities in ovarian cancer survival among ethnic Asian American populations, 2006-2020. Gynecol Oncol. 2024. PMID: 39488866. doi:10.1016/j.ygyno.2024.10.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。